Transcriptional Regulation and Its Misregulation in Disease

Available in PMC 2014 March 14.

Bibliographic Details
Main Authors: Lee, Tong Ihn (Author), Young, Richard A (Author), Young, Richard A. (Contributor)
Other Authors: Massachusetts Institute of Technology. Department of Biology (Contributor), Whitehead Institute for Biomedical Research (Contributor)
Format: Article
Language:English
Published: Elsevier, 2016-08-11T20:38:08Z.
Subjects:
Online Access:Get fulltext
LEADER 01312 am a22002413u 4500
001 103908
042 |a dc 
100 1 0 |a Lee, Tong Ihn  |e author 
100 1 0 |a Massachusetts Institute of Technology. Department of Biology  |e contributor 
100 1 0 |a Whitehead Institute for Biomedical Research  |e contributor 
100 1 0 |a Young, Richard A.  |e contributor 
700 1 0 |a Young, Richard A.  |e author 
700 1 0 |a Young, Richard A.  |e author 
245 0 0 |a Transcriptional Regulation and Its Misregulation in Disease 
260 |b Elsevier,   |c 2016-08-11T20:38:08Z. 
856 |z Get fulltext  |u http://hdl.handle.net/1721.1/103908 
520 |a Available in PMC 2014 March 14. 
520 |a The gene expression programs that establish and maintain specific cell states in humans are controlled by thousands of transcription factors, cofactors, and chromatin regulators. Misregulation of these gene expression programs can cause a broad range of diseases. Here, we review recent advances in our understanding of transcriptional regulation and discuss how these have provided new insights into transcriptional misregulation in disease. 
520 |a National Institutes of Health (U.S.) (NIH grant CA146445) 
520 |a National Institutes of Health (U.S.) (NIH grant HG002668) 
546 |a en_US 
655 7 |a Article 
773 |t Cell